Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lithium increases 5-HT-mediated prolactin release.

S L McCance1, P R Cohen, P J Cowen

  • 1MRC Unit of Clinical Pharmacology, Littlemore Hospital, Oxford, UK.

Psychopharmacology
|January 1, 1989
PubMed
Summary

Short-term lithium treatment enhanced prolactin release in response to clomipramine in male volunteers. This suggests lithium may selectively boost serotonin pathways, potentially aiding treatment-resistant depression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

No benefit from flexible titration above minimum licensed dose in prescribing antidepressants for major depression: systematic review.

Acta psychiatrica Scandinavica·2020
Same author

The effects of serotonin modulation on medial prefrontal connectivity strength and stability: A pharmacological fMRI study with citalopram.

Progress in neuro-psychopharmacology & biological psychiatry·2018
Same author

How do drugs for psychiatric disorders work?

Epidemiology and psychiatric sciences·2017
Same author

Interferon-α induces negative biases in emotional processing in patients with hepatitis C virus infection: a preliminary study.

Psychological medicine·2017
Same author

Backing into the future: pharmacological approaches to the management of resistant depression.

Psychological medicine·2017
Same author

Melatonin as a treatment for mood disorders: a systematic review.

Acta psychiatrica Scandinavica·2017

Area of Science:

  • Neuropharmacology
  • Endocrinology

Background:

  • Lithium is a mood stabilizer used in treating bipolar disorder.
  • Serotonin (5-HT) pathways are implicated in depression and mood regulation.

Purpose of the Study:

  • To investigate the effect of short-term lithium on prolactin and cortisol responses to specific neurochemical challenges.
  • To explore the potential selective enhancement of serotonin-mediated prolactin release by lithium.

Main Methods:

  • Male volunteers received short-term lithium treatment (3-4 days).
  • Prolactin and cortisol levels were measured after intravenous administration of clomipramine, metoclopramide, and haloperidol.

Main Results:

  • Lithium significantly enhanced prolactin response to clomipramine.
  • Lithium did not alter prolactin response to haloperidol or metoclopramide.
  • Lithium did not affect cortisol response to clomipramine.

Conclusions:

  • Lithium may selectively enhance 5-HT mediated prolactin release.
  • Synergistic effects of lithium and clomipramine on brain 5-HT function could be relevant for treating resistant depression.

Related Experiment Videos